InSilicoMinds is a new Avicenna member!
29/01/2024
We are thrilled to welcome InSilicoMinds among the Avicenna Alliance members.
InSilicoMinds accelerates drug development and regulatory approvals using AI, modeling and simulation solutions.
With their team of experienced life sciences, digital innovation, and in silico experts working together to provide in silico solutions, InSilicoMinds will provide an unmatched expertise to the Avicenna's AI and Pharma Task Force, not mentioning other activities. Similarly, the Avicenna Alliance will bring a lot of value by sharing connections, resources and know-how with InSilicoMinds!
An amazing win-win collaboration that will benefit the patients.
Find out more about InSilicoMinds...